Literature DB >> 1130436

Sickle cell anemia- clinical manifestations in 100 patients and review of the literature.

G Karayalcin, F Rosner, K Y Kim, P Chandra, A J Aballi.   

Abstract

The clinical and hematological features of 100 patients with sickle cell anemia are reviewed. The heart was enlarged and a murmur was heard in nearly 80 percent of patients. Pneumonia and pulmonary infarction occurred in 43 percent and 12 percent of patients, respectively. Musculoskeletal involvement included the hand-foot syndrome (15 percent), leg ulcers (55 percent), aseptic necrosis ofbone (11 percent), and osteomyelitis (4 percent). Symptoms and signs related to the gastrointestinal system included jaundice (55 percent), hepatomegaly (50 percent), splenomegaly (23 percent), hepatitis (11 percent) and gallstones (9 percent). Three patients underwent cholecystectomy and three patients had their spleens removed. Pyelonephritis occurred in 17 patients, priapism in five and hematuria in seven. Nineteen women had 39 pregnancies, of which 35 resulted in the birth of healthy infants. At least 328 painful crises occurred in 73 patients. There were also 13 hemolytic crises, eight sequestration crises, and five aplastic crises. A trail of alkali therapy in 33 crises in children failed to produce beneficial effects greater than hydration and analgesics alone as used in the control group. Laboratory findings in the 100 patients were comparable to those previously reported in the literature. The renal concentrating defect in most patients was confirmed. There were six deaths: hepatic coma secondary to post-transfusion hepatitis, thrombosis of inferior vena cava, congestive heart failure, exsanguination from erosion of the pancreaticoduodenal artery, extensive bronchopneumonia, and pulmonary infarction.

Entities:  

Mesh:

Year:  1975        PMID: 1130436     DOI: 10.1097/00000441-197501000-00007

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  10 in total

1.  Pleural effusion in sickle cell disease.

Authors:  A E Oestreich
Journal:  J Natl Med Assoc       Date:  1977-08       Impact factor: 1.798

2.  Common bacterial infections in infancy and childhood. 5. Infections of the skeletal system.

Authors:  G A Ahronheim
Journal:  Drugs       Date:  1978-09       Impact factor: 9.546

3.  Hemodynamic response to exercise in patients with sickle cell anemia.

Authors:  M E McConnell; S R Daniels; J Lobel; F W James; S Kaplan
Journal:  Pediatr Cardiol       Date:  1989       Impact factor: 1.655

4.  Refractory sickle cell leg ulcer: is heparan sulphate a new hope?

Authors:  Shady Hayek; Saad Dibo; Joe Baroud; Amir Ibrahim; Denis Barritault
Journal:  Int Wound J       Date:  2014-02-21       Impact factor: 3.315

5.  The spine in sickle cell disease.

Authors:  M Sadat-Ali; A Ammar; J R Corea; A W Ibrahim
Journal:  Int Orthop       Date:  1994-06       Impact factor: 3.075

6.  The significance of gallstones in children with sickle cell anemia.

Authors:  C Alexander-Reindorf; R U Nwaneri; R G Worrell; A Ogbonna; C Uzoma
Journal:  J Natl Med Assoc       Date:  1990-09       Impact factor: 1.798

7.  Cardiac manifestations of sickle cell anaemia in Sudanese children.

Authors:  Ghada O M Ali; Yahya S Abdal Gader; Elfatih S Abuzedi; Bakhieta A I Attalla
Journal:  Sudan J Paediatr       Date:  2012

Review 8.  Myocardial infarction in sickle cell disease.

Authors:  Ishak A Mansi; Fred Rosner
Journal:  J Natl Med Assoc       Date:  2002-06       Impact factor: 1.798

Review 9.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01

10.  Impact of voxelotor (GBT440) on unconjugated bilirubin and jaundice in sickle cell disease.

Authors:  Paul Telfer; Irene Agodoa; Kathleen M Fox; Laurie Burke; Timothy Mant; Marzena Jurek; Margaret Tonda; Josh Lehrer-Graiwer
Journal:  Hematol Rep       Date:  2018-05-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.